Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Inivata
With
Guardian Research Network, Inc.
The primary aim of this study is to investigate the concordance of Inivata liquid biopsy panel with standard tissue biopsy analysis for detecting genomic alterations in patients with advanced non-squamous non-small cell lung cancer (NSCLC).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Written, signed and dated informed consent
Male \& female patients aged 18 years and over diagnosed with stage IIIb/IV non-squamous NSCLC.
Patients intended to initiate first-line treatment (Arms A and B)
Patients who plan to have or have had a recent tumor tissue biopsy taken as part of their standard of care (Arm A)
Patient must understand and be able, willing and likely to fully comply with all study procedures and restrictions.
You may not be if
Patients who have received any approved or experimental cancer therapy since their most recent NSCLC tissue biopsy
Any history of metastatic cancer.
Previous malignancy in the last 2 years (except basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix).
Patient with a severe acute or chronic medical or psychiatric condition or laboratory abnormality
